Qrons's - QRON market analysis on 19th January 2021

Transaction Date	Recipient	Shares	Type	Price	Value

Qrons

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.

Qrons, Inc. is a preclinical stage biotechnology company. The company was founded by Jonah Martin Meer and Ido Merfeldon August 22, 2016 and is headquartered in New York, NY.

Ticker: QRON

Sector: Health Technology

Industry: Biotechnology

SEC Central Index Key (CIK): 1689084

Employees: 4

Exchange: US OTC

Auditor Opinion:

You must Login to see Language Changes

Disclosure Language changes

Analysis of subtle changes in disclosure language. Red is a sign of more constrained, less positive language changes etc. Green is more positive, less constrained etc.

You must Login to see analysis